Try it
Pathology · Neoplasia: gastrointestinal stromal tumour
Sample itemA 60-year-old man has a gastric submucosal mass. Histology shows spindle cells that are positive for CD117 and DOG1. From which cell does this tumour arise, and which drug is the targeted therapy of choice?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Interstitial cells of Cajal; imatinib
Gastrointestinal stromal tumours arise from interstitial cells of Cajal or their precursors, usually through activating mutations of KIT or PDGFRA. Imatinib inhibits these tyrosine kinases and is used in advanced disease and adjuvantly in high-risk resected tumours.
Option by option
A. Schwann cells; sunitinib
Schwannomas are S-100 positive and are not KIT driven.
B. Interstitial cells of Cajal; imatinib (correct)
Cajal cell origin with KIT-driven growth responds to imatinib.
C. Smooth muscle of the muscularis propria; surgery only
Leiomyomas arise from smooth muscle and are desmin positive, whereas this tumour is CD117 positive.
D. Gastric neuroendocrine cells; octreotide
Neuroendocrine tumours express chromogranin and synaptophysin rather than CD117 and DOG1.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pathology questions
- HaematopathologyBinucleate 'owl-eye' cells that stain for CD15 and CD30 are characteristic of which cond…
- NeuropathologyEosinophilic intracytoplasmic inclusions in the pigmented neurons of the substantia nigr…
- HaemodynamicsWhich of the following is NOT a component of Virchow's triad for thrombosis?
- Granulomatous diseaseNon-caseating granulomas with Schaumann bodies and asteroid bodies are typical of: